PRESS RELEASE
Grand-Fougeray, October 8, 2026
GENEO Capital Entrepreneur announces its investment in Lodigroup, a French manufacturer specializing in biosecurity and building protection, alongside the company’s management and BNP Paribas Développement.
This initial transaction, carried out by GENEO and BNP Paribas Développement, aims to support a new phase of the group’s development in France and Europe, particularly through targeted acquisitions and continued innovation. Alexis Lockman retains majority control of Lodigroup and is reinvesting alongside Marie-Laure Biannic. The transaction exemplifies GENEO’s approach to this type of deal: providing operational support by jointly developing a growth roadmap with management to advance a long-term entrepreneurial vision.
Industrial expertise in the service of biosecurity
Founded in 1981 by Robert Lockman and headquartered in Grand-Fougeray, Brittany, Lodigroup designs, formulates, manufactures, and distributes solutions for pest control, the protection of stored foodstuffs, and building maintenance. The group serves pest control professionals, the agricultural and food industries, local governments, and building professionals.
Under the leadership of Alexis Lockman, who acquired a majority stake in the company in 2014, and Marie-Laure Biannic, Lodigroup has strengthened its industrial, scientific, and regulatory capabilities. In particular, the acquisition of Dalep in 2017 expanded the company’s expertise to include products for the treatment, cleaning, and protection of building exteriors.
Lodigroup has seven locations in France and the United Kingdom, including three manufacturing sites in Brittany and Normandy. Operating in more than 35 countries, the group has over 160 employees and generated more than 70 million euros in revenue in 2025.
Continuing to innovate to advance protection solutions
The group relies on two research and development laboratories and a design office established in 2023 that specializes in mechanical and electrical systems. These capabilities enable the group to combine improvements to its formulations with the design of new solutions for trapping and monitoring pests.
The goal is to expand the range of solutions offered to customers by combining—depending on the application—conventional solutions, low-dose formulations, and trapping devices. This integrated pest management approach aims to maintain the effectiveness of protection while reducing the use of active ingredients.
A “Growth Journal” to Support Lodigroup’s European Ambitions
GENEO’s support will be structured around a customized “Growth Plan” focused on four priorities: targeted acquisitions in France and Europe, expanding the product portfolio, commercial and international development, and strengthening the organization. GENEO will mobilize its teams, its “business partners,” and its network of experts to support Lodigroup from the identification of targets through their integration and, more broadly, to support its European expansion.
“Our goal is to strengthen our position in France and take our business to the next level across Europe. We want to expand our offerings, develop our sales networks, and make complementary acquisitions, drawing on the expertise of our teams. With GENEO and the continued support of BNP Paribas Développement, we aim to accelerate our growth in Europe and enhance our protection solutions, while maintaining control over our entrepreneurial vision,”, said Alexis Lockman, president, and Marie-Laure Biannic, CEO and chief scientific officer of Lodigroup.
“Lodigroup combines industrial know-how, scientific and regulatory expertise, and a management team that has demonstrated its ability to grow the group. Our ambition is to support this new phase in a very concrete way by implementing a growth roadmap developed in collaboration with the group’s management. It is this combination of an entrepreneurial vision and operational support that gives our investment its full meaning,”, says François Picarle, partner at GENEO Capital
“BNP Paribas Développement has been supporting Lodigroup since 2014. We are enthusiastic about supporting the management team and the company, and we welcome GENEO’s arrival as the company enters this new phase of development,” said Yannick Carré, Director of Portfolio Investments at BNP Paribas Développement:
About Lodigroup
Founded in 1981 and headquartered in Grand-Fougeray, Lodigroup is a French industrial group specializing in biosecurity and building protection. Through its subsidiaries Lodi and Dalep, it operates in the fields of public health, rural health, the protection of stored foodstuffs, and exterior building maintenance. The group integrates research and development, formulation, manufacturing, and distribution.
About GENEO Capital Entrepreneur
Through its “evergreen” investment firm, GENEO Capital Entrepreneur provides agile capital that adapts to the pace of each company with responsiveness and flexibility. As a business partner, it provides operational and human support for the execution of business plans through a “Growth Playbook” tailored to each company, as well as access to specialized “business partners” and a network of experts. Its community of more than 280 families and entrepreneurs offers a unique opportunity to share experiences and access a business network unlike any other in France.
For more information: www.geneocapitalentrepreneur.com
About BNP Paribas Développement
BNP Paribas Développement, a subsidiary of the international banking group BNP Paribas, is a corporation that has, for more than 38 years, directly invested its own capital as a minority shareholder to support the growth of high-performing small and medium-sized enterprises (SMEs) and mid-market companies and ensure their long-term viability by facilitating their succession. Beyond the financial resources made available to the company to ensure stable funding, BNP Paribas Développement’s mission is to provide long-term support to the management team in carrying out its medium-term strategic projects. Our minority stake ensures our partners have appropriate governance without interference in day-to-day management, while allowing them to benefit from the strength of a recognized group and the experience of a partner with a diversified portfolio of more than 600 investments.
More information: https://www.bnpparibasdeveloppement.com/
https://www.linkedin.com/company/bnp-paribas-développement
Press contact
For GENEO Capital Entrepreneur:
Hugues de Tournemire – 06 67 07 22 33 – geneo@rudpedersen.com
Stakeholders in the operation:
Sellers: Alexis Lockman, Marie-Laure Biannic, BNP Paribas Développement (Yannick Carré, Maxime Morel)
Buyers: GENEO (François Picarle, Antoine Riley, Laetitia Daou), BNP Paribas Développement (Yannick Carré, Maxime Morel), Alexis Lockman, Marie-Laure Biannic
M&A Advisory, Sellers: Edmond de Rothschild CF (Nicolas Manceau, Sébastien Brasy, Océane Barbieri, Guillaume Ung), GEF (Bernard Gougeon)
Financial Advisory: Edmond de Rothschild CF (Paul Assaël, Carlos Martinez)
Legal Counsel, Sellers: MB&A (Sylvain Narainsamy, Marie Wecxsteen)
VDD Financière: BM&A (Guilhem de Montmarin, Adrien Klinkenberg, Brice Carrier)
Strategic VDD: CMI (Nicolas Kandel, Olivier Oriez, Julie Berthet)
Legal Counsel, Banking: Agilys (David Kalfon, Carolle Thain-Navarro, Rabah Meddour)
Banks: Caisse d’Epargne Bretagne Pays de Loire, Crédit Agricole d’Ille-et-Vilaine, Banque Populaire Grand Ouest, Société Générale
Legal Counsel, Buyers: Joffe & Associates (Romain Soiron, Aymeric Dégremont)
Financial Advisors, Buyers: Advolis Orfis (Damien Bourg, Marion Bernadou)
Environmental Consulting for Buyers : Ramboll (Bertille Crichton, Michel MacCabe)
Regulatory Advice for Acquirers : Nexialist (Marie-Pierre Roger, Lucile Collard)
